A. Nascimbeni

发表

ER–plasma membrane contact sites contribute to autophagosome biogenesis by regulation of local PI3P synthesis

P. Codogno, M. Vaccaro, A. Nascimbeni, 2017, The EMBO journal.

Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers

A. Scarpa, C. Bassi, A. Mafficini, 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Guidelines for the use and interpretation of assays formonitoring autophagy (3rd edition)

Sangeeta Khare, Xin Qi, Ying Wang, 2016 .

Autophagy: A Druggable Process.

P. Codogno, M. Mehrpour, J. Botti, 2017, Annual review of pharmacology and toxicology.

To be or not to be cell autonomous? Autophagy says both.

P. Codogno, A. Nascimbeni, N. Dupont, 2017, Essays in biochemistry.

Phenotype modulators in myophosphorylase deficiency

C. Angelini, G. Siciliano, P. Tonin, 2003, Annals of neurology.

Phosphatidylinositol‐3‐phosphate in the regulation of autophagy membrane dynamics

P. Codogno, A. Nascimbeni, E. Morel, 2017, The FEBS journal.

Molecular Mechanisms of Noncanonical Autophagy.

P. Codogno, A. Nascimbeni, N. Dupont, 2017, International review of cell and molecular biology.

Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes

C. Angelini, E. Ricci, G. Piluso, 2005, Journal of Medical Genetics.

The extensive scanning of the calpain-3 gene broadens the spectrum of LGMD 2 A phenotypes

Enzo, C. Angelini, G. Piluso, 2004 .

The frequency of limb girdle muscular dystrophy 2A in northeastern Italy

C. Angelini, A. Nascimbeni, M. Fanin, 2005, Neuromuscular Disorders.

The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B)

C. Angelini, A. Nascimbeni, M. Fanin, 2010, Neurological research.

Autophagy dysregulation in Danon disease

C. Angelini, M. Sandri, A. Nascimbeni, 2017, Cell Death & Disease.

The role of autophagy in the pathogenesis of glycogen storage disease type II (GSDII)

C. Angelini, M. Sandri, E. Masiero, 2012, Cell Death and Differentiation.

- 181-Multisystemic LAMP-2 defect in Danon disease

C. Angelini, A. Nascimbeni, M. Fanin, 2008 .

Multisystemic LAMP-2 defect in Danon disease.

C. Angelini, A. Nascimbeni, M. Fanin, 2007 .

Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease.

C. Angelini, A. Nascimbeni, M. Fanin, 2006, The American journal of pathology.

Lipolysis and lipophagy in lipid storage myopathies

C. Angelini, A. Nascimbeni, G. Cenacchi, 2016, Biochimica et biophysica acta.

PI3KC2α-dependent and VPS34-independent generation of PI3P controls primary cilium-mediated autophagy in response to shear stress

P. Codogno, E. Hirsch, A. Nascimbeni, 2020, Nature Communications.

Impaired autophagy contributes to muscle atrophy in glycogen storage disease type II patients

C. Angelini, M. Sandri, E. Masiero, 2012, Autophagy.

Impaired autophagy affects acid α‐glucosidase processing and enzyme replacement therapy efficacy in late‐onset glycogen storage disease type II

C. Angelini, M. Sandri, A. Nascimbeni, 2015, Neuropathology and applied neurobiology.

Muscle atrophy, ubiquitin–proteasome, and autophagic pathways in dysferlinopathy

C. Angelini, A. Nascimbeni, M. Fanin, 2014, Muscle & nerve.

Molecular pathology and enzyme processing in various phenotypes of acid maltase deficiency

C. Angelini, A. Nascimbeni, M. Fanin, 2008, Neurology.

Local detection of PtdIns3P at autophagosome biogenesis membrane platforms

P. Codogno, A. Nascimbeni, E. Morel, 2017, Autophagy.

Autophagy in Natural History and After ERT in Glycogenosis Type II.

C. Angelini, A. Nascimbeni, M. Fanin, 2015, JIMD reports.

Therapeutic advances in the management of Pompe disease and other metabolic myopathies

C. Angelini, A. Nascimbeni, C. Semplicini, 2013, Therapeutic advances in neurological disorders.

Epilepsy and limb girdle muscular dystrophy type 2A: double trouble, serendipitous finding or new phenotype?

L. Murri, M. Mancuso, G. Siciliano, 2006, Neurological Sciences.

Long-term follow-up results in enzyme replacement therapy for Pompe disease: a case report

A. Cerutti, C. Angelini, L. Giordano, 2010, Journal of Inherited Metabolic Disease.

Dominant muscular dystrophy with a novel SYNE1 gene mutation

C. Angelini, A. Nascimbeni, V. Nigro, 2015, Muscle & nerve.

Late‐onset GSDII with novel GAA gene mutation

C. Angelini, A. Nascimbeni, A. Nascimbeni, 2007, Clinical genetics.

Frequency of LGMD gene mutations in Italian patients with distinct clinical phenotypes

C. Angelini, E. Pegoraro, A. Nascimbeni, 2009, Neurology.

How to tackle the diagnosis of limb-girdle muscular dystrophy 2A

C. Angelini, A. Nascimbeni, M. Fanin, 2009, European Journal of Human Genetics.

An intronic mutation causes severe LGMD2A in a large inbred family belonging to a genetic isolate in the Alps

C. Angelini, A. Nascimbeni, F. Benedicenti, 2012, Clinical genetics.

Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures

Francesco Muntoni, Marika Pane, Vincenzo Nigro, 2005, Neuromuscular Disorders.

Screening of calpain-3 autolytic activity in LGMD muscle: a functional map of CAPN3 gene mutations

C. Angelini, A. Nascimbeni, M. Fanin, 2006, Journal of Medical Genetics.

PI3KC2α-dependent and VPS34-independent generation of PI3P controls primary cilium-mediated autophagy in response to shear stress

P. Codogno, E. Hirsch, A. Nascimbeni, 2020, Nature Communications.

Primary cilium-dependent autophagy drafts PIK3C2A to generate PtdIns3P in response to shear stress

P. Codogno, A. Nascimbeni, N. Dupont, 2020, Autophagy.

Fine-tuning autophagy: from transcriptional to posttranslational regulation.

P. Codogno, A. Nascimbeni, N. Dupont, 2016, American journal of physiology. Cell physiology.

Autophagy Is Required for Memory Formation and Reverses Age-Related Memory Decline

P. Codogno, Allyson K. Friedman, S. Moriceau, 2019, Current Biology.

McArdle's disease. The unsolved mystery of the reappearing enzyme.

A. Martinuzzi, A. Nascimbeni, M. Fanin, 1999, The American journal of pathology.

Adult acid maltase deficiency: an open trial with albuterol and branched- chain aminoacids

C. Angelini, E. Pegoraro, L. Vergani, 2004 .

Gender difference in limb-girdle muscular dystrophy: a muscle fiber morphometric study in 101 patients.

C. Angelini, A. Nascimbeni, M. Fanin, 2014, Clinical neuropathology.

Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression.

C. Angelini, A. Nascimbeni, M. Fanin, 2003, The American journal of pathology.

Transcriptional and Translational Effects of Intronic CAPN3 Gene Mutations

C. Angelini, A. Nascimbeni, M. Fanin, 2010, Human mutation.

Heterogeneous pathogenesis of LGMD 2 : consequences for therapy

C. Angelini, A. Nascimbeni, M. Fanin, 2008 .

Correlations between clinical severity, genotype and muscle pathology in limb girdle muscular dystrophy type 2A

C. Angelini, A. Nascimbeni, M. Fanin, 2007, Journal of Medical Genetics.

dystrophy type 2A and muscle pathology in limb girdle muscular Correlations between clinical severity, genotype

A. Nascimbeni, M. Fanin, L. Nardetto, 2007 .

Muscle fatigue, nNOS and muscle fiber atrophy in limb girdle muscular dystrophy

C. Angelini, A. Nascimbeni, M. Fanin, 2014, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

Sarcolemmal Neuronal Nitric Oxide Synthase Defect in Limb-Girdle Muscular Dystrophy: An Adverse Modulating Factor in the Disease Course?

C. Angelini, A. Nascimbeni, M. Fanin, 2009, Journal of neuropathology and experimental neurology.

S2.1 Enzyme replacement therapy (ERT) in Glycogen Storage Disease Type II: the first treatment developed

C. Angelini, E. Pegoraro, A. Nascimbeni, 2011, Acta Myologica.

ER-driven membrane contact sites: Evolutionary conserved machineries for stress response and autophagy regulation?

P. Codogno, A. Nascimbeni, F. Giordano, 2017, Communicative & integrative biology.

Autophagosomal membranes assemble at ER-plasma membrane contact sites

P. Codogno, A. Nascimbeni, E. Morel, 2017, Molecular & Cellular Oncology.

Incomplete penetrance in limb‐girdle muscular dystrophy type 1F

C. Angelini, A. Nascimbeni, A. Torella, 2015, Muscle & nerve.

Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

Sara W. Bird, Erinna F. Lee, Michael D. Kim, 2016 .

Muscle protein analysis in the detection of heterozygotes for recessive limb girdle muscular dystrophy type 2B and 2E

C. Angelini, A. Nascimbeni, M. Fanin, 2006, Neuromuscular Disorders.

gene mutations CAPN3 muscle: a functional map of Screening of calpain-3 autolytic activity in LGMD

C. Angelini, A. Nascimbeni, M. Fanin, 2007 .

Molecular diagnosis in LGMD2A: Mutation analysis or protein testing?

C. Angelini, G. Siciliano, G. Piluso, 2004, Human mutation.

Molecular Mechanisms of Noncanonical Autophagy.

P. Codogno, A. Nascimbeni, N. Dupont, 2017, International Review of Cell and Molecular Biology.